Revolution Medicines, Inc. Profile Avatar - Palmy Investing

Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial f…
Biotechnology
US, Redwood City [HQ]
RVMD/Financials
Supply · Problems · Premarket · Compliance

Supply Analysis

Supply Analysis
End of RVMD's Analysis
CIK: 1628171 CUSIP: 76155X100 ISIN: US76155X1000 LEI: - UEI: -
Secondary Listings
RVMD has no secondary listings inside our databases.